New meetings & grants, with a focus on Vietnam, China, and the UK

Dear All: Below my signature, find details of 4 new meetings and (collectively) 4 active or upcoming grant opportunities. One of the grants has a 6 Sep deadline, so look quickly! At the very bottom of the email you will find an integrated summary of all upcoming meetings … there is a lot going on!

I hope to see you at next week’s ASM-ESCMID conference for the first episodes of the CARB-Xed + GARDP Bootcamp for Developers Series. Until then, all best wishes, –jr

John H. Rex, MD | Chief Medical Officer, F2G Ltd. | Chief Strategy Officer, CARB-X | Expert-in-Residence, Wellcome Trust. Follow me on Twitter: @JohnRex_NewAbx. See past newsletters and subscribe for the future: http://amr.solutions/blog/

 ————————————-
Meetings, two of which are preludes to grant competitions

  • 1 Oct 2017 and 2 Nov 2017 (London): BSAC: AMR Market Lounges. A pair of networking days focused on solutions to the AMR challenge.
  • 10 Oct 2017 (Hanoi): UK-Vietnam Newton Fund Pre-Call Workshop on Partnership for Infectious Disease Research 2017. This is a workshop in Hanoi in advance of a call for Newton Fund*-supported proposals from the collaboration between UK MRC and the -Vietnamese Ministry of Science and Technology (MOST).
  • 20 Nov 2017 (that week, in China): UK-China Newton Fund Workshop: Antimicrobial Resistance Centre Partnerships Initiative. This is a workshop in China in advance of a call for Newton Fund*-supported proposals from the collaboration between Research Councils UK (RCUK) and the National Natural Science Foundation of China (NSFC).
  • 20 Nov 2017 (London): Early Career Researcher Workshop on Diagnostics for Antimicrobial Resistance. This will be a one-day workshop for early career researchers which will include invited experts “to provide inspiration, encourage interdisciplinary networking, and explore the barriers and opportunities facing the development of rapid diagnostics for infectious disease.”

*The Newton Fund builds scientific and innovation partnerships with 16 partner countries to support their economic development and social welfare, and to develop their research and innovation capacity for long-term sustainable growth. It has a total UK Government investment of £735 million up until 2021, with matched resources from the partner countries. The Newton Fund is managed by the UK Department for Business, Energy and Industrial Strategy (BEIS), and delivered through 15 UK Delivery Partners, which include the Research Councils, the UK National Academies, the British Council, Innovate UK and the Met Office.

​ ————————————-
Other grant opportunities

​ ————————————-
Integrated summary of upcoming meetings of interest to the AMR community:

Share

Impact of PASTEUR: 9.9m lives saved, ROI of 125:1

Impact of PASTEUR: 9.9m lives saved, ROI of 125:1 Dear All (and with thanks to Kevin Outterson for being lead author on this newsletter), (wonkish alert on this one … refresh your coffee and dig in!) The Center for Global Development have released a blog post and a paper estimating the potential impact of the PASTEUR Act.

Five FDA RFPs! Antifungal animal models, MIC breakpoints, and more!

Dear All, I just today learned that FDA have posted their FY 2023 funding opportunities. All the details are on this webpage and I’m just going to reproduce the text below my signature for your reference. I’ll also add a few details in italics. Lots of good opportunities here! –jr John H. Rex, MD |

WAAW! Must-Read Article, A Quiz, A Video, A Call to Action

Notes: Newsflash … BARDA have opened their long-running BAA-18-100-SOL-00003 to include support for antifungal agents. Search for “antifungal” in the posted .pdf to find the text. The first deadline for proposals is 15 Dec 2022 and further deadlines will doubtless follow: as shown on page 9, this BAA has offered 4 deadlines/year since 2018!  Dear All, In

Fireside Chat with AMR Action Fund CIO Martin Heidecker

Dear All, Ahead of World Antimicrobial Awareness Week, I sat down with AMR Action Fund Chief Investment Officer Martin Heidecker for a Fireside Chat. It was a fabulous conversation that covered everything from how the Fund’s investment process works to what it’s looking for in portfolio companies to broader investment trends in the AMR space.  As

Scroll to Top